News

GlaxoSmithKline (GSK) has reported the results from the clinical trial assessing Pandemrix. GSK’s adjuvanted H1N1 pandemic influenza vaccine, Pandemrix is administered at the same time as the annual

Genmab has initiated a Phase III study of Arzerra ofatumumab plus chemotherapy versus rituximab plus chemotherapy to treat patients with relapsed or refractory diffuse large B-cell lymphoma (DLBCL).

Concert Pharmaceuticals has initiated a Phase 1b clinical study with CTP-518, investigational oral HIV protease inhibitor for the treatment of HIV infection. In connection with the start of

Zosano Pharma has revealed results from a positive Phase 2 study of its rapid-delivery transdermal patch (ZP-PTH) for the treatment of postmenopausal osteoporosis. The results were published in

Bayer MaterialScience (Bayer) has expanded the capacity of Desmodur N aliphatic coatings raw materials at its integrated site in Caojing, near Shanghai in China. The company said that

Evotec has extended the research collaboration with Boehringer Ingelheim for a further 4 years, based on the success to date in the areas of CNS, inflammation, cardiometabolic and

Halozyme (Halozyme) and ProMetic Life Sciences (ProMetic) have entered into a long-term supply agreement for a proprietary synthetic ligand affinity adsorbent manufactured by ProMetic’s UK subsidiary, ProMetic BioSciences.

Natrol has been recently certified by the Natural Products Association (NPA) current Good Manufacturing Practices (cGMP) certification program which incorporates the FDA final cGMP rule. Jenia Khudagulyan, senior

NexBio has presented new data entitled ‘DAS181 (Fludase), a Sialidase, Decreases Airway Resistance and Has Potent Anti-inflammatory Effects in Animal Models of Asthma’. DAS181 (Fludase) is an investigational